These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11005939)

  • 1. Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.
    Sarnak MJ; Levey AS
    J Thromb Thrombolysis; 2000 Oct; 10(2):169-80. PubMed ID: 11005939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of vascular disease in renal failure.
    Ikizler TA
    Blood Purif; 2002; 20(1):6-10. PubMed ID: 11803153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequate treatment of cardiovascular disease and cardiovascular disease risk factors in dialysis patients: a commentary.
    Culleton BF; Hemmelgarn B
    Semin Dial; 2004; 17(5):342-5. PubMed ID: 15461738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
    Bostom AG; Shemin D; Lapane KL; Nadeau MR; Sutherland P; Chan J; Rozen R; Yoburn D; Jacques PF; Selhub J; Rosenberg IH
    Atherosclerosis; 1996 Jun; 123(1-2):193-202. PubMed ID: 8782850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular risk factors and renal failure].
    Madore F
    Med Sci (Paris); 2004 Dec; 20(12):1100-3. PubMed ID: 15581463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and underlying cardiovascular diseases in incident ESRD patients.
    Di Benedetto A; Marcelli D; D'Andrea A; Cice G; D'Isa S; Cappabianca F; Pacchiano G; D'Amato R; Oggero AR; Bonanno D; Pergamo O; Calabrò R
    J Nephrol; 2005; 18(5):592-8. PubMed ID: 16299687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.
    K/DOQI Workgroup
    Am J Kidney Dis; 2005 Apr; 45(4 Suppl 3):S1-153. PubMed ID: 15806502
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular disease in dialysis patients.
    Cozzolino M; Mangano M; Stucchi A; Ciceri P; Conte F; Galassi A
    Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii28-iii34. PubMed ID: 30281132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorenal risk factors.
    Wall BM
    Am J Med Sci; 2010 Jul; 340(1):25-9. PubMed ID: 20610968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reverse epidemiology in chronic kidney disease: beyond traditional explanations].
    Massy ZA
    Nephrol Ther; 2008 Jul; 4(4):221-2. PubMed ID: 18485857
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular risk in chronic renal disease and transplantation prevention and management.
    Malyszko J; Malyszko JS; Bachorzewska-Gajewska H
    Expert Opin Pharmacother; 2005 Jun; 6(6):929-43. PubMed ID: 15952921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.
    Tonelli M; Karumanchi SA; Thadhani R
    Circulation; 2016 Feb; 133(5):518-36. PubMed ID: 26831434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter.
    Levin A; Djurdjev O; Barrett B; Burgess E; Carlisle E; Ethier J; Jindal K; Mendelssohn D; Tobe S; Singer J; Thompson C
    Am J Kidney Dis; 2001 Dec; 38(6):1398-407. PubMed ID: 11728982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring cardiovascular risk factors in children on dialysis.
    Shroff R
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S173-5. PubMed ID: 19270210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Thromb Res; 2014 Sep; 134(3):711-6. PubMed ID: 25065558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S112-9. PubMed ID: 9820470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.